Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026)
Cureus · 25.07.2026
DOI: 10.7759/cureus.113371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 25.07.2026. Verfasst von Abhinandan Singla und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Mercy St. Vincent Medical Center, Toledo, USA. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Mercy St. Vincent Medical Center, Toledo, USA.
- Medicine, Government Medical College, Amritsar, IND.
- Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, USA.
- Internal Medicine, Henry Ford Macomb Hospital, Detroit, USA.
- Cardiology, Mercy St. Vincent Medical Center, Toledo, USA.
- Interventional Cardiology, Mercy St. Vincent Medical Center, Toledo, USA.
Zitieren
APA
Singla, A., Kaur, G., Singh, G., Luthra, S., Lodha, C., Alneser, O., Alo, M. S., Ali, S. S., & Zulqarnain, M. (2026). Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026). Cureus. https://doi.org/10.7759/cureus.113371
Vancouver
Singla A, Kaur G, Singh G, Luthra S, Lodha C, Alneser O, et al. Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026). Cureus. 2026. doi:10.7759/cureus.113371
BibTeX
@article{Singla2026,
author = {Singla, Abhinandan and Kaur, Gurnoor and Singh, Gurpreet and Luthra, Shivansh and Lodha, Chirag and Alneser, Omar and Alo, Mohammed S and Ali, Syed S and Zulqarnain, Muhammad},
title = {Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026)},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.113371}
}
EUVIMED